wjz-13 all-news-99-1-wnew 1057-the-fan 1300logo2_67x35

Local

Carlyle Group Funds Fight Of Lou Gehrig’s Disease

View Comments
(Photo by Ron Sachs-Pool/Getty Images)

(Photo by Ron Sachs-Pool/Getty Images)

CBS Baltimore (con't)

Affordable Care Act Updates:
CBSBaltimore.com/ACA

Health News & Information:
CBSBaltimore.com/Health

WASHINGTON (AP) — Bloomberg LP CEO Daniel Doctoroff is joining with New York City Mayor Michael Bloomberg and David Rubenstein of Washington-based private equity firm The Carlyle Group to fund a $25 million initiative for treatment of Lou Gehrig’s disease.

They announced the three-year initiative called Target ALS on Thursday to provide a new system for sharing and coordinating findings among researchers. It will be managed by researchers at Columbia University Medical Center.

Target ALS is the next phase of a research initiative of New York-based Project A.L.S. and the Packard Center for ALS Research at Johns Hopkins University in Baltimore.

Researchers say the short-term goal is to facilitate drug-development programs at pharmaceutical and biotech companies. The longer-term goal is to find effective therapies for the disease.

(Copyright 2013 by The Associated Press. All Rights Reserved.)

View Comments
blog comments powered by Disqus